• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经静脉-动脉体外膜肺氧合支持的创新性绵羊严重心肺衰竭模型。

An innovative ovine model of severe cardiopulmonary failure supported by veno-arterial extracorporeal membrane oxygenation.

机构信息

Critical Care Research Group, The Prince Charles Hospital, Chermside, Brisbane, QLD, Australia.

Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.

出版信息

Sci Rep. 2021 Oct 14;11(1):20458. doi: 10.1038/s41598-021-00087-y.

DOI:10.1038/s41598-021-00087-y
PMID:34650063
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8516938/
Abstract

Refractory cardiogenic shock (CS) often requires veno-arterial extracorporeal membrane oxygenation (VA-ECMO) to sustain end-organ perfusion. Current animal models result in heterogenous cardiac injury and frequent episodes of refractory ventricular fibrillation. Thus, we aimed to develop an innovative, clinically relevant, and titratable model of severe cardiopulmonary failure. Six sheep (60 ± 6 kg) were anaesthetized and mechanically ventilated. VA-ECMO was commenced and CS was induced through intramyocardial injections of ethanol. Then, hypoxemic/hypercapnic pulmonary failure was achieved, through substantial decrease in ventilatory support. Echocardiography was used to compute left ventricular fractional area change (LVFAC) and cardiac Troponin I (cTnI) was quantified. After 5 h, the animals were euthanised and the heart was retrieved for histological evaluations. Ethanol (58 ± 23 mL) successfully induced CS in all animals. cTnI levels increased near 5000-fold. CS was confirmed by a drop in systolic blood pressure to 67 ± 14 mmHg, while lactate increased to 4.7 ± 0.9 mmol/L and LVFAC decreased to 16 ± 7%. Myocardial samples corroborated extensive cellular necrosis and inflammatory infiltrates. In conclusion, we present an innovative ovine model of severe cardiopulmonary failure in animals on VA-ECMO. This model could be essential to further characterize CS and develop future treatments.

摘要

难治性心原性休克(CS)常需要静脉-动脉体外膜肺氧合(VA-ECMO)来维持终末器官灌注。目前的动物模型导致心脏损伤不均一,频繁出现难治性心室颤动。因此,我们旨在开发一种创新的、与临床相关的、可滴定的严重心肺衰竭模型。六只绵羊(60±6kg)麻醉并机械通气。开始 VA-ECMO,通过心肌内注射乙醇诱导 CS。然后,通过大幅降低通气支持来实现低氧/高碳酸血症性肺衰竭。使用超声心动图计算左心室射血分数(LVFAC),并定量检测心肌肌钙蛋白 I(cTnI)。5 小时后,处死动物并取出心脏进行组织学评估。所有动物均成功接受乙醇(58±23mL)注射以诱导 CS。cTnI 水平增加近 5000 倍。CS 通过收缩压降至 67±14mmHg 来确认,同时乳酸增加到 4.7±0.9mmol/L,LVFAC 降至 16±7%。心肌样本证实存在广泛的细胞坏死和炎症浸润。总之,我们在接受 VA-ECMO 的动物中展示了一种新型的严重心肺衰竭绵羊模型。该模型对于进一步描述 CS 和开发未来治疗方法可能至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/5e2aeb69e6be/41598_2021_87_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/8e5c02519143/41598_2021_87_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/92b1314b6b0e/41598_2021_87_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/1c53f0930936/41598_2021_87_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/1db65dc20454/41598_2021_87_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/37b234a2961e/41598_2021_87_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/5e2aeb69e6be/41598_2021_87_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/8e5c02519143/41598_2021_87_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/92b1314b6b0e/41598_2021_87_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/1c53f0930936/41598_2021_87_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/1db65dc20454/41598_2021_87_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/37b234a2961e/41598_2021_87_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fe16/8516938/5e2aeb69e6be/41598_2021_87_Fig6_HTML.jpg

相似文献

1
An innovative ovine model of severe cardiopulmonary failure supported by veno-arterial extracorporeal membrane oxygenation.经静脉-动脉体外膜肺氧合支持的创新性绵羊严重心肺衰竭模型。
Sci Rep. 2021 Oct 14;11(1):20458. doi: 10.1038/s41598-021-00087-y.
2
Two-stage weaning strategy using veno-veno-arterial perfusion for patients on extracorporeal membrane oxygenation following cardiogenic shock.对心源性休克后接受体外膜肺氧合治疗的患者采用静脉-静脉-动脉灌注的两阶段撤机策略。
Perfusion. 2019 Nov;34(8):689-695. doi: 10.1177/0267659119841862. Epub 2019 May 13.
3
Veno-arterial extracorporeal membrane oxygenation for electrical injury induced cardiogenic shock support: a case report.静脉-动脉体外膜肺氧合用于电损伤所致心源性休克支持:一例报告
J Cardiothorac Surg. 2020 Jun 17;15(1):143. doi: 10.1186/s13019-020-01188-x.
4
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for emergency cardiac support.静脉-动脉体外膜肺氧合(VA-ECMO)用于紧急心脏支持。
J Crit Care. 2018 Apr;44:31-38. doi: 10.1016/j.jcrc.2017.10.011. Epub 2017 Oct 12.
5
A rationale for early extracorporeal membrane oxygenation in patients with postinfarction ventricular septal rupture complicated by cardiogenic shock.梗死后室间隔破裂并心原性休克患者早期体外膜肺氧合的理由。
Eur J Heart Fail. 2017 May;19 Suppl 2:97-103. doi: 10.1002/ejhf.852.
6
Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors.难治性心源性休克的体外膜肺氧合支持:治疗策略及危险因素分析
Artif Organs. 2014 Jul;38(7):E129-41. doi: 10.1111/aor.12317. Epub 2014 May 20.
7
"Awake Veno-arterial Extracorporeal Membrane Oxygenation" in Pediatric Cardiogenic Shock: A Single-Center Experience.小儿心源性休克中“清醒静脉 - 动脉体外膜肺氧合”:单中心经验
Pediatr Cardiol. 2015 Dec;36(8):1647-56. doi: 10.1007/s00246-015-1211-8. Epub 2015 Jun 7.
8
Extracorporeal Membrane Oxygenation in the Emergency Department.急诊科的体外膜肺氧合
Emerg Med Clin North Am. 2020 Nov;38(4):945-959. doi: 10.1016/j.emc.2020.06.015. Epub 2020 Sep 9.
9
VA-ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors.非手术难治性心源性休克患者的VA-ECMO支持:植入前结局预测因素
Artif Organs. 2019 Feb;43(2):132-141. doi: 10.1111/aor.13331. Epub 2018 Nov 6.
10
Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry.药物性心原性休克患者应用静脉-动脉体外膜肺氧合(VA-ECMO)的临床效果:体外生命支持组织 ECMO 病例登记库的一项回顾性研究。
Clin Toxicol (Phila). 2020 Jul;58(7):705-710. doi: 10.1080/15563650.2019.1676896. Epub 2019 Oct 16.

引用本文的文献

1
Effect of flow change on brain injury during an experimental model of differential hypoxaemia in cardiogenic shock supported by extracorporeal membrane oxygenation.体外膜肺氧合支持下心源性休克差异性低氧血症实验模型中血流变化对脑损伤的影响。
Sci Rep. 2023 Mar 10;13(1):4002. doi: 10.1038/s41598-023-30226-6.
2
Effectiveness and Safety of a Prolonged Hemodynamic Support by the IVAC2L System in Healthy and Cardiogenic Shock Pigs.IVAC2L系统对健康和心源性休克猪进行长时间血流动力学支持的有效性和安全性
Front Cardiovasc Med. 2022 Feb 8;9:809143. doi: 10.3389/fcvm.2022.809143. eCollection 2022.
3
A clinically relevant sheep model of orthotopic heart transplantation 24 h after donor brainstem death.

本文引用的文献

1
Left Ventricular Unloading Is Associated With Lower Mortality in Patients With Cardiogenic Shock Treated With Venoarterial Extracorporeal Membrane Oxygenation: Results From an International, Multicenter Cohort Study.左心室卸载与使用体外膜肺氧合治疗的心源性休克患者的死亡率降低相关:一项国际多中心队列研究的结果。
Circulation. 2020 Dec;142(22):2095-2106. doi: 10.1161/CIRCULATIONAHA.120.048792. Epub 2020 Oct 9.
2
Large Animal Models of Heart Failure: A Translational Bridge to Clinical Success.心力衰竭的大型动物模型:通往临床成功的转化桥梁。
JACC Basic Transl Sci. 2020 Aug 24;5(8):840-856. doi: 10.1016/j.jacbts.2020.04.011. eCollection 2020 Aug.
3
一种在供体脑干死亡24小时后进行原位心脏移植的具有临床相关性的绵羊模型。
Intensive Care Med Exp. 2021 Dec 24;9(1):60. doi: 10.1186/s40635-021-00425-4.
A total closed chest sheep model of cardiogenic shock by percutaneous intracoronary ethanol injection.
经皮冠状动脉内注射乙醇致羊心源休克的全闭式胸腔模型。
Sci Rep. 2020 Jul 24;10(1):12417. doi: 10.1038/s41598-020-68571-5.
4
How I approach weaning from venoarterial ECMO.我如何进行静脉-动脉体外膜肺氧合的撤机。
Crit Care. 2020 Jun 8;24(1):307. doi: 10.1186/s13054-020-03010-5.
5
Heart failure supported by veno-arterial extracorporeal membrane oxygenation (ECMO): a systematic review of pre-clinical models.静脉-动脉体外膜肺氧合(ECMO)支持的心力衰竭:临床前模型的系统评价
Intensive Care Med Exp. 2020 May 25;8(1):16. doi: 10.1186/s40635-020-00303-5.
6
Contemporary trends in use of mechanical circulatory support in patients with acute MI and cardiogenic shock.急性心肌梗死合并心源性休克患者使用机械循环支持的当代趋势。
Open Heart. 2020 Mar 4;7(1):e001214. doi: 10.1136/openhrt-2019-001214. eCollection 2020.
7
Management of cardiogenic shock complicating myocardial infarction: an update 2019.心肌梗死并发心源性休克的治疗:2019 年更新
Eur Heart J. 2019 Aug 21;40(32):2671-2683. doi: 10.1093/eurheartj/ehz363.
8
Venoarterial Extracorporeal Membrane Oxygenation for Cardiopulmonary Support.用于心肺支持的静脉-动脉体外膜肺氧合
Circulation. 2018 Nov 13;138(20):2298-2300. doi: 10.1161/CIRCULATIONAHA.118.036691.
9
ECMO improves survival following cardiogenic shock due to carbon monoxide poisoning - an experimental porcine model.体外膜肺氧合(ECMO)可提高一氧化碳中毒性心源性休克患者的存活率——一种实验性猪模型。
Scand J Trauma Resusc Emerg Med. 2018 Nov 22;26(1):103. doi: 10.1186/s13049-018-0570-6.
10
Heart-lung interactions during mechanical ventilation: the basics.机械通气期间的心-肺相互作用:基础
Ann Transl Med. 2018 Sep;6(18):349. doi: 10.21037/atm.2018.04.29.